Human medicines European public assessment report (EPAR): Firazyr, icatibant, Angioedemas, Hereditary, Date of authorisation: 11/07/2008, Revision: 16, Status: Authorised
[开放获取] 拉那利尤单抗治疗遗传性血管性水肿临床试验的系统综述
Treatment and disease burden of hereditary angioedema